ORTEXORTEX News
Tracking HRTG? Get live short interest, options flow, and signals on ORTEX.Sign up free →
HR
Earnings PreviewHRTG

HRTG Falls 6% in a Week While Insiders Sell and Shorts Pile Back In

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 29 Oct 2026, 04:11

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Heritage Insurance Holdings dropped 6.3% over the past week to $34.73, a move that stands out against a median gain of 0.9% across its closest peers. UVE slipped 1.4% on the week, JRVR fell 2.6%, while ALL and PGR both edged higher. Heritage's underperformance is not happening in a vacuum: it arrives on earnings day with short interest rising and corporate insiders selling at every opportunity.

Short positions have climbed 14% in the past week to roughly 726,000 shares, or 2.5% of the free float. That level is modest in absolute terms, but the direction matters: shorts had been retreating through October, falling from about 870,000 shares at the start of the month, only to reverse sharply in the final week before the print. Borrowing costs remain cheap at 0.50%, and availability is extremely loose, leaving ample room for new shorts to establish positions without any squeeze risk.

The insider picture is harder to dismiss. Heritage's CEO, Ernie Garateix, sold shares on three separate occasions since mid-August, none of them under a pre-arranged 10b5-1 plan. The CFO sold 10,000 shares in August, also discretionary. The Chief Accounting Officer sold twice in September, one of those sales under a plan and one not. Net insider activity over the past 90 days totals a disposal of roughly 85,600 shares worth approximately $2.9 million. These are not large transactions relative to the company's $1 billion market cap, but the pattern, repeated discretionary sales from the CEO and CFO at prices close to where the stock trades today, is the kind of signal that merits attention heading into a quarterly report.

Analyst opinion provides the counterweight. Truist Securities carries a Buy with a $42 target, raised from $36 after the last quarterly print in August when the stock jumped 8% on the day. Piper Sandler maintains Overweight at $31. Raymond James initiated at Market Perform in October without a target, bringing the formal consensus to a hold split between two ratings. The bull case rests on a 73% jump in book value per share over the past year, $393 million in statutory surplus reserves, and a price-to-earnings ratio that has compressed to around 5x, cheap relative to specialty property and casualty peers. Bears point to falling policy counts in Florida, ongoing competitive pricing pressure, and the ever-present risk that a major storm rewrites the reinsurance cost structure in a single quarter.

Options positioning offers no strong directional signal. The put/call ratio of 0.37 is slightly below its 20-day average of 0.38, suggesting the market is neither bracing for a sell-off nor aggressively positioned for a rally. The print will test whether the book value expansion that drove the stock's earlier 2026 gains is translating into durable earnings momentum, or whether the pattern of insider selling and the late-week short interest build reflects something the quarterly numbers are about to confirm.

Stocks in this article

See the live data behind this article on ORTEX.

Open HRTG on ORTEX →

How this article was generated

Generated
29 Oct 2026, 04:44
Data as of
29 Oct 2026, 04:11
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.